查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613341

診斷契約製造市場：按類型、服務、應用分類 - 2025-2030 年全球預測

Diagnostic Contract Manufacturing Market by Type, Services, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年診斷契約製造市場的市場規模為286.3億美元，預計到2024年將達到314.9億美元，複合年成長率為10.37%，到2030年將達到571.4億美元。

診斷契約製造是指將診斷試劑的開發和生產外包給專業的第三方製造商。該部門主要致力於醫療診斷並生產試劑、化驗和分析儀器等基本組件。對診斷契約製造的需求是由對具有成本效益的解決方案不斷成長的需求、對簡化生產的需求以及無需昂貴的資本投資即可快速擴大營運規模的能力所推動的。應用範圍廣泛，包括基因檢測、感染疾病診斷和個人化醫療，我們為醫院、診所和實驗室等最終用戶提供服務。

主要市場統計
基準年[2023] 286.3億美元
預測年份 [2024] 314.9億美元
預測年份 [2030] 571.4億美元
複合年成長率（%） 10.37%

市場成長在很大程度上受到醫療保健支出增加、診斷自動化和人工智慧等技術進步以及需要高級診斷的慢性病和感染疾病增加的影響。此外，COVID-19 大流行加速了對強大診斷解決方案的需求，並進一步強調了對契約製造的需求。關鍵的商機在於提供多樣化的分子診斷和個人化醫療解決方案，並將服務擴展到疾病盛行率高但診斷能力低的新興市場。公司應該投資與生技公司和醫療保健提供者的合作夥伴關係，以加強產品系列和市場覆蓋範圍。

然而，市場面臨監管要求嚴格、競爭激烈、智慧財產權保密等挑戰。目標市場的經濟限制也可能是限制因素。為了克服這些障礙，專注於數位健康診斷和遠端醫療應用的創新可能會帶來變革。透過投資小型化診斷設備的研發並整合物聯網解決方案，公司可以吸引注重成本且精通技術的受眾。市場競爭激烈，但創新時機已經成熟，動態格局需要敏捷性和策略夥伴關係，以抓住新興機會並有效應對挑戰。

市場動態：快速發展的診斷合約契約製造市場的關鍵市場洞察

診斷契約製造市場正在因供需的動態交互作用而發生轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 診斷公司對成本效益和最佳化流程的高要求
    • 提高預防醫學意識並擴大診斷測試的採用
  • 市場限制因素
    • 與建立製造設施相關的高成本
  • 市場機會
    • 診斷製造過程中的技術進步
    • 開發契約製造的永續和綠色方法
  • 市場挑戰
    • 確保產品品質和智慧財產權相關的風險

波特的五力戰略工具駕馭診斷合約契約製造市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解診斷試劑契約製造市場的外部影響

外部宏觀環境因素在塑造診斷契約製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解診斷試劑契約製造市場的競爭狀況

診斷契約製造市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣診斷合約契約製造市場供應商績效評估

FPNV定位矩陣是評估診斷契約製造市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 繪製診斷合約契約製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對診斷契約製造市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 診斷公司對具有成本效益和最佳化流程的高需求
      • 提高預防保健意識並增加診斷測試的採用
    • 抑制因素
      • 建立生產設施的成本很高
    • 機會
      • 診斷製造流程的技術進步
      • 在契約製造中發展永續和環保的實踐
    • 任務
      • 確保產品品質和智慧財產權相關的風險
  • 市場區隔分析
    • 類型：自有品牌製造服務對於進入新市場或以最少的投資增強現有產品線的需求很高。
    • 應用：更多採用診斷成像設備的診斷試劑契約製造服務
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 診斷試劑契約製造市場：按類型

  • 端對端製造
  • 個別零件製造
  • 分包勞務或服務；
  • 自有品牌製造

第7章 診斷試劑契約製造市場：依服務分類

  • 包裝和組裝服務
  • 產品開發及製造服務
  • 品管服務

第8章 診斷試劑契約製造市場：依應用分類

  • 影像診斷設備
  • 配方開發
  • 體外診斷設備

第9章 北美、南美診斷試劑契約製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太診斷契約製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲診斷試劑契約製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FUJIREBIO和 Agappe 之間的策略性業務聯盟加強了診斷解決方案
    • Axim Biotechnologies 透過與 Auer Precision 合作加強檢測生產
    • Almac 集團透過對卓越診斷製造的策略投資進行擴張
  • 戰略分析和建議

公司名單

  • Argonaut Manufacturing Services Inc.
  • Bio-Techne Corporation
  • Celestica Inc.
  • Comar
  • Donatelle
  • EKF Diagnostics Holdings PLC
  • FlexMedical Solutions
  • Fortis Life Sciences
  • Gerresheimer AG
  • Invetech
  • Invetech Pty. Ltd.
  • Jabil Inc.
  • Keller Technology Corporation
  • KMC Systems by Elbit Systems Ltd.
  • LaunchWorks CDMO
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Prestige Diagnostics
  • Sanmina Corporation
  • Savyon Diagnostics
  • SCHOTT AG
  • TCS Biosciences
  • TE Connectivity Ltd.
  • TECHLAB, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-7A22CB0E649D

The Diagnostic Contract Manufacturing Market was valued at USD 28.63 billion in 2023, expected to reach USD 31.49 billion in 2024, and is projected to grow at a CAGR of 10.37%, to USD 57.14 billion by 2030.

Diagnostic Contract Manufacturing encompasses the outsourcing of diagnostic product development and production to specialized third-party manufacturers. This sector caters primarily to medical diagnostics, producing essential components like reagents, assays, and analytical instruments. The necessity for diagnostic contract manufacturing stems from the growing demand for cost-effective solutions, the need for streamlined production, and the capability to scale operations rapidly without hefty capital investments. Applications range widely, including genetic testing, infectious disease diagnostics, and personalized medicine, serving end-users such as hospitals, clinics, and laboratories.

KEY MARKET STATISTICS
Base Year [2023] USD 28.63 billion
Estimated Year [2024] USD 31.49 billion
Forecast Year [2030] USD 57.14 billion
CAGR (%) 10.37%

The market growth is largely influenced by increasing healthcare expenditure, technological advancements such as automation and AI in diagnostics, and the rise in chronic and infectious diseases necessitating advanced diagnostics. Furthermore, the COVID-19 pandemic accelerated demand for robust diagnostic solutions, further emphasizing the need for contract manufacturing. Key opportunities lie in diversifying offerings in molecular diagnostics and personalized medical solutions, as well as expanding services into emerging markets with a high prevalence of diseases but lower diagnostic capabilities. Companies should invest in partnerships with biotech firms and healthcare providers to enhance product portfolio and market reach.

However, the market faces challenges including stringent regulatory requirements, high competition, and confidentiality concerns regarding intellectual property. Economic constraints in target markets can also be a limiting factor. To overcome these hurdles, focusing on innovations in digital health diagnostics and telemedicine applications could be transformative. By investing in R&D for miniaturized diagnostic devices and integrating IoT-enabled solutions, companies can appeal to the cost-conscious and technologically savvy segments. The market is competitive, yet ripe for innovation, with a dynamic landscape demanding agility and strategic partnerships to capture burgeoning opportunities and address the challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diagnostic Contract Manufacturing Market

The Diagnostic Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High demand for cost-effective and optimized processes by diagnostic companies
    • Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
  • Market Restraints
    • High cost associated with setting up manufacturing facility
  • Market Opportunities
    • Technological advancement in diagnostic manufacturing processes
    • Development of sustainable and green practices in contract manufacturing
  • Market Challenges
    • Risk associated with ensuring product quality and intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Diagnostic Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diagnostic Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diagnostic Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diagnostic Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diagnostic Contract Manufacturing Market

A detailed market share analysis in the Diagnostic Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diagnostic Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diagnostic Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diagnostic Contract Manufacturing Market

A strategic analysis of the Diagnostic Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diagnostic Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Argonaut Manufacturing Services Inc., Bio-Techne Corporation, Celestica Inc., Comar, Donatelle, EKF Diagnostics Holdings PLC, FlexMedical Solutions, Fortis Life Sciences, Gerresheimer AG, Invetech, Invetech Pty. Ltd., Jabil Inc., Keller Technology Corporation, KMC Systems by Elbit Systems Ltd., LaunchWorks CDMO, Merck KGaA, Microcoat Biotechnologie GmbH, Prestige Diagnostics, Sanmina Corporation, Savyon Diagnostics, SCHOTT AG, TCS Biosciences, TE Connectivity Ltd., TECHLAB, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Diagnostic Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across End-to-End Manufacturing, Individual Component Manufacturing, Labor or Service Subcontracting, and Private Label Manufacturing.
  • Based on Services, market is studied across Packaging & Assembly Services, Product Development & Manufacturing Services, and Quality Management Services.
  • Based on Application, market is studied across Diagnostic Imaging Devices, Formulation Development, and In Vitro Diagnostic Devices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High demand for cost-effective and optimized processes by diagnostic companies
      • 5.1.1.2. Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with setting up manufacturing facility
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in diagnostic manufacturing processes
      • 5.1.3.2. Development of sustainable and green practices in contract manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with ensuring product quality and intellectual property rights
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing demand for private label manufacturing services aimed at entering new markets or augmenting existing product lines with minimal investment
    • 5.2.2. Application: Rising adoption of diagnostic contract manufacturing services for diagnostic imaging devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diagnostic Contract Manufacturing Market, by Type

  • 6.1. Introduction
  • 6.2. End-to-End Manufacturing
  • 6.3. Individual Component Manufacturing
  • 6.4. Labor or Service Subcontracting
  • 6.5. Private Label Manufacturing

7. Diagnostic Contract Manufacturing Market, by Services

  • 7.1. Introduction
  • 7.2. Packaging & Assembly Services
  • 7.3. Product Development & Manufacturing Services
  • 7.4. Quality Management Services

8. Diagnostic Contract Manufacturing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Imaging Devices
  • 8.3. Formulation Development
  • 8.4. In Vitro Diagnostic Devices

9. Americas Diagnostic Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diagnostic Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diagnostic Contract Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Strategic Business Collaboration Between Fujirebio and Agappe Enhances Diagnostic Solutions
    • 12.3.2. Axim Biotechnologies Boosts Assay Production Through Auer Precision Partnership
    • 12.3.3. Expansion of Almac Group Through a Strategic Investment in Diagnostic Manufacturing Excellence
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argonaut Manufacturing Services Inc.
  • 2. Bio-Techne Corporation
  • 3. Celestica Inc.
  • 4. Comar
  • 5. Donatelle
  • 6. EKF Diagnostics Holdings PLC
  • 7. FlexMedical Solutions
  • 8. Fortis Life Sciences
  • 9. Gerresheimer AG
  • 10. Invetech
  • 11. Invetech Pty. Ltd.
  • 12. Jabil Inc.
  • 13. Keller Technology Corporation
  • 14. KMC Systems by Elbit Systems Ltd.
  • 15. LaunchWorks CDMO
  • 16. Merck KGaA
  • 17. Microcoat Biotechnologie GmbH
  • 18. Prestige Diagnostics
  • 19. Sanmina Corporation
  • 20. Savyon Diagnostics
  • 21. SCHOTT AG
  • 22. TCS Biosciences
  • 23. TE Connectivity Ltd.
  • 24. TECHLAB, Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIAGNOSTIC CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY END-TO-END MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY INDIVIDUAL COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY LABOR OR SERVICE SUBCONTRACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRIVATE LABEL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & ASSEMBLY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT DEVELOPMENT & MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY QUALITY MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023